menu
    • menu

    Company profile for Acticor Biotech SAS

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Acticor Biotech is a biopharmaceutical company developing an antithrombotic agent for the treatment of the acute phase of ischemic stroke. Acticor Biotech is a spin-off company from Inserm (French National Institute of Health and Medical Research) founded in November 2013 and located in the Inserm U1148 building inside the Bichat Hospital in Paris. Acticor Biotech develops a biologic drug candidate based on academic research o...
    Acticor Biotech is a biopharmaceutical company developing an antithrombotic agent for the treatment of the acute phase of ischemic stroke. Acticor Biotech is a spin-off company from Inserm (French National Institute of Health and Medical Research) founded in November 2013 and located in the Inserm U1148 building inside the Bichat Hospital in Paris. Acticor Biotech develops a biologic drug candidate based on academic research on a platelet glycoprotein called GPVI. GPVI is a platelet receptor of collagen and polymerized fibrin.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Acticor Biotech SASFrance Flag
    Country
    Country
    France
    Address
    Address
    Bichat Hospital - INSERM U1148 46, Henri Huchard Street 75018 PARIS
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.acticor-biotech.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/acticor-biotech
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/acticorbiotech

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Acticor halts phase 2/3 stroke trial for blood thinner over futility
    Acticor halts phase 2/3 stroke trial for blood thinner over futility

    26 Jul 2024

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/acticor-halts-phase-23-stroke-trial-blood-thinner-over-futility

    FIERCE BIOTECH
    26 Jul 2024
    Share Share
    ACTICOR Adapts Its ACTISAVE Study to Prepare the Registration of Glenzocimab
    ACTICOR Adapts Its ACTISAVE Study to Prepare the Registration of Glenzocimab

    14 Sep 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230914727576/en

    BUSINESSWIRE
    14 Sep 2023
    Share Share
    Acticor Biotech: Progress in Discussions with EU and US Regulatory Agencies
    Acticor Biotech: Progress in Discussions with EU and US Regulatory Agencies

    30 May 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230530005540/en

    BUSINESSWIRE
    30 May 2023
    Share Share
    Update on Acticor Biotech's clinical developments with glenzocimab
    Update on Acticor Biotech's clinical developments with glenzocimab

    09 Jan 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230109005745/en

    BUSINESSWIRE
    09 Jan 2023
    Share Share
    Acticor Biotech Receives EMA Endorsement on Key Parameters of ACTISAVE
    Acticor Biotech Receives EMA Endorsement on Key Parameters of ACTISAVE

    05 Dec 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20221205005453/en

    BUSINESSWIRE
    05 Dec 2022
    Share Share
    Acticor and University of Birmingham partner for heart attack drug trial
    Acticor and University of Birmingham partner for heart attack drug trial

    23 Nov 2022

    // CLINICALTRIALSARENA

    https://www.clinicaltrialsarena.com/news/acticor-heart-attack-trial/

    CLINICALTRIALSARENA
    23 Nov 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search